Review: Biochemical markers to predict preeclampsia

Placenta

Volumn 33, Issue SUPPL., 2012, Pages

  Anderson, U D ^a   Olsson, M G ^a   Kristensen, K H ^a   Akerstrom B ^a   Hansson, S R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

A1M; Alpha 1 microglobulin; Biochemical markers; Fetal hemoglobin; HbF; PAPP A; PlGF; PP13; Prediction; Preeclampsia; sflt 1

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOGENIC FACTOR; BIOCHEMICAL MARKER; CYSTATIN C; ENDOGLIN; HEMOGLOBIN F; PLACENTA PROTEIN; PLACENTAL PROTEIN 13; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

CONFERENCE PAPER; ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; METABOLOMICS; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEOMICS; RISK FACTOR; SENSITIVITY ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; MASS SCREENING; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84856001518     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.11.021     Document Type: Conference Paper

References (67)

1. J.M. Roberts, and D.W. Cooper Pathogenesis and genetics of pre-eclampsia Lancet 357 9249 2001 Jan 6 53 56 (Pubitemid 32056505)
2. J.M. Stevens Gynaecology from ancient Egypt: The Papyrus Kahun: a translation of the oldest treatise on gynaecology that has survived from the ancient world Med J Aust 2 25-26 1975 Dec 20-27 949 952
3. J.M. Roberts, and C.A. Hubel The two stage model of preeclampsia: variations on the theme Placenta 30 Suppl. A 2009 Mar S32 S37
4. J.J. Brosens, R. Pijnenborg, and I.A. Brosens The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature Am J Obstet Gynecol 187 5 2002 Nov 1416 1423 (Pubitemid 35397496)
5. J.M. Roberts, and C.A. Hubel Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354 9181 1999 Sep 4 788 789 (Pubitemid 29415578)
6. A.H. Shennan, L. Poston, L.C. Chappell, and P.T. Seed Prevention of pre-eclampsia Lancet 357 9267 2001 May 12 1534
7. T.H. Hung, J.N. Skepper, D.S. Charnock-Jones, and G.J. Burton Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia Circ Res 90 12 2002 Jun 28 1274 1281 (Pubitemid 34787409)
8. U.D. Anderson, M.G. Olsson, S. Rutardottir, M. Centlow, K.H. Kristensen, and P.E. Isberg Fetal hemoglobin and alpha(1)-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia Am J Obstet Gynecol 204(6) 520 2011 Jun e1 e5
9. K. May, L. Rosenlof, M.G. Olsson, M. Centlow, M. Morgelin, and I. Larsson Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by alpha1-microglobulin Placenta 32 4 2011 Apr 323 332
10. G.J. Burton, and E. Jauniaux Oxidative stress Best Pract Res Clin Obstet Gynaecol 25 3 2011 Jun 287 299
11. H. Lipstein, C.C. Lee, and R.S. Crupi A current concept of eclampsia Am J Emerg Med 21 3 2003 May 223 226 (Pubitemid 36734688)
12. M.A. Brown, M.D. Lindheimer, M. de Swiet, A. Van Assche, and J.M. Moutquin The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 1 2001 IX XIV
13. B.M. Schroeder ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists Am Fam Physician 66 2 2002 Jul 15 330 331 (Pubitemid 34810086)
14. C.W. Redman, and I.L. Sargent Latest advances in understanding preeclampsia Science 308 5728 2005 Jun 10 1592 1594 (Pubitemid 40807500)
15. K. Duckitt, and D. Harrington Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ 330 7491 2005 Mar 12 565
16. R. Akolekar, A. Syngelaki, R. Sarquis, M. Zvanca, and K.H. Nicolaides Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks Prenat Diagn 31 1 2011 Jan 66 74
17. J.G. Westergaard, B. Teisner, and J.G. Grudzinskas Serum PAPP-A in normal pregnancy: relationship to fetal and maternal characteristics Arch Gynecol 233 3 1983 211 215 (Pubitemid 13075048)
18. K.O. Kagan, D. Wright, C. Valencia, N. Maiz, and K.H. Nicolaides Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A Hum Reprod 23 9 2008 Sep 1968 1975
19. J.K. Ranta, K. Raatikainen, J. Romppanen, K. Pulkki, and S. Heinonen Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption Eur J Obstet Gynecol Reprod Biol 157 1 2011 Jul 48 52
20. A.O. Odibo, Y. Zhong, M. Longtine, M. Tuuli, L. Odibo, and A.G. Cahill First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction Placenta 32 4 2011 Apr 333 338
21. K. Spencer, C.K. Yu, N.J. Cowans, C. Otigbah, and K.H. Nicolaides Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler Prenat Diagn 25 10 2005 Oct 949 953 (Pubitemid 41494994)
22. G.C. Smith, E.J. Stenhouse, J.A. Crossley, D.A. Aitken, A.D. Cameron, and J.M. Connor Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth J Clin Endocrinol Metab 87 4 2002 Apr 1762 1767 (Pubitemid 34615266)
23. K.R. Goetzinger, A. Singla, S. Gerkowicz, J.M. Dicke, D.L. Gray, and A.O. Odibo Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG Prenat Diagn 30 12-13 2010 Dec 1138 1142
24. L.C. Poon, N. Maiz, C. Valencia, W. Plasencia, and K.H. Nicolaides First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia Ultrasound Obstet Gynecol 33 1 2009 Jan 23 33
25. K. Spencer, N.J. Cowans, and K.H. Nicolaides Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia Prenat Diagn 28 1 2008 Jan 7 10 (Pubitemid 351251982)
26. A. Atis, T. Tandogan, Y. Aydin, C. Sen, F. Turgay, and N. Eren Late pregnancy associated plasma protein A levels decrease in preterm labor J Matern Fetal Neonatal Med 24 7 2011 Jul 923 927
27. M. Centlow, P. Carninci, K. Nemeth, E. Mezey, M. Brownstein, and S.R. Hansson Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes Fertil Steril 90 5 2008 Nov 1834 1843
28. V.A. Tsemakhovich, V.V. Bamm, M. Shaklai, and N. Shaklai Vascular damage by unstable hemoglobins: the role of heme-depleted globin Arch Biochem Biophys 436 2 2005 Apr 15 307 315 (Pubitemid 40576270)
29. D.B. Kim-Shapiro, A.N. Schechter, and M.T. Gladwin Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics Arterioscler Thromb Vasc Biol 26 4 2006 Apr 697 705 (Pubitemid 43732141)
30. S. Kumar, and U. Bandyopadhyay Free heme toxicity and its detoxification systems in human Toxicol Lett 157 3 2005 Jul 4 175 188 (Pubitemid 40726102)
31. M. Allhorn, T. Berggard, J. Nordberg, M.L. Olsson, and B. Akerstrom Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties Blood 99 6 2002 Mar 15 1894 1901 (Pubitemid 34525466)
32. B. Akerstrom, G.J. Maghzal, C.C. Winterbourn, and A.J. Kettle The lipocalin alpha1-microglobulin has radical scavenging activity J Biol Chem 282 43 2007 Oct 26 31493 31503 (Pubitemid 350063946)
33. M.G. Olsson, M. Centlow, S. Rutardottir, I. Stenfors, J. Larsson, and B. Hosseini-Maaf Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia Free Radic Biol Med 48 2 2010 Jan 15 284 291
34. M.G. Olsson, T. Olofsson, H. Tapper, and B. Akerstrom The lipocalin alpha1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species Free Radic Res 42 8 2008 Aug 725 736
35. M.G. Olsson, M. Allhorn, T. Olofsson, and B. Akerstrom Up-regulation of alpha1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines Free Radic Biol Med 42 6 2007 Mar 15 842 851 (Pubitemid 46274169)
36. N.G. Than, E. Pick, S. Bellyei, A. Szigeti, O. Burger, and Z. Berente Functional analyses of placental protein 13/galectin-13 Eur J Biochem 271 6 2004 Mar 1065 1078 (Pubitemid 38373040)
37. B. Visegrady, N.G. Than, F. Kilar, B. Sumegi, G.N. Than, and H. Bohn Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13) Protein Eng 14 11 2001 Nov 875 880 (Pubitemid 34024179)
38. R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, and K.H. Nicolaides Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia Prenat Diagn 29 12 2009 Dec 1103 1108
39. A. Khalil, N.J. Cowans, K. Spencer, S. Goichman, H. Meiri, and K. Harrington First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk Ultrasound Obstet Gynecol 35 6 2010 Jun 671 679
40. R. Romero, J.P. Kusanovic, N.G. Than, O. Erez, F. Gotsch, and J. Espinoza First-trimester maternal serum PP13 in the risk assessment for preeclampsia Am J Obstet Gynecol 199 2 2008 Aug 122e1 122e11
41. K.H. Nicolaides, R. Bindra, O.M. Turan, I. Chefetz, M. Sammar, and H. Meiri A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound Ultrasound Obstet Gynecol 27 1 2006 Jan 13 17 (Pubitemid 43129084)
42. A. Stamatopoulou, N.J. Cowans, E. Matwejew, C. von Kaisenberg, and K. Spencer Placental Protein-13 and pregnancy-associated plasma Protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes Hypertens Pregnancy 2010 Aug 11
43. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 7 2004 Feb 12 672 683 (Pubitemid 38364626)
44. R.J. Levine, C. Lam, C. Qian, K.F. Yu, S.E. Maynard, and B.P. Sachs Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 10 2006 Sep 7 992 1005 (Pubitemid 44343543)
45. S. Maynard, F.H. Epstein, and S.A. Karumanchi Preeclampsia and angiogenic imbalance Annu Rev Med 59 2008 61 78 (Pubitemid 351287924)
46. A. Reddy, S. Suri, I.L. Sargent, C.W. Redman, and S. Muttukrishna Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia PLoS One 4 2 2009 e4453
47. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 5 2003 Mar 649 658 (Pubitemid 36278583)
48. A.K. Wikstrom, A. Larsson, U.J. Eriksson, P. Nash, S. Norden-Lindeberg, and M. Olovsson Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia Obstet Gynecol 109 6 2007 Jun 1368 1374 (Pubitemid 46869876)
49. Z. Li, Y. Zhang, J. Ying Ma, A.M. Kapoun, Q. Shao, and I. Kerr Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia Hypertension 50 4 2007 Oct 686 692 (Pubitemid 47442732)
50. O. Erez, R. Romero, J. Espinoza, W. Fu, D. Todem, and J.P. Kusanovic The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 5 2008 May 279 287 (Pubitemid 351652513)
51. J.M. Foidart, C. Munaut, F. Chantraine, R. Akolekar, and K.H. Nicolaides Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia Ultrasound Obstet Gynecol 35 6 2010 Jun 680 687
52. R. Akolekar, J. de Cruz, J.M. Foidart, C. Munaut, and K.H. Nicolaides Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia Prenat Diagn 30 3 2010 Mar 191 197
53. S. Verlohren, A. Galindo, D. Schlembach, H. Zeisler, I. Herraiz, and M.G. Moertl An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia Am J Obstet Gynecol 202 2 2010 Feb 161e1 161e11
54. A. De Vivo, G. Baviera, D. Giordano, G. Todarello, F. Corrado, and R. D'Anna Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia Acta Obstet Gynecol Scand 87 8 2008 837 842
55. L.C. Kenny, D.I. Broadhurst, W. Dunn, M. Brown, R.A. North, and L. McCowan Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers Hypertension 56 4 2010 Oct 741 749
56. K. Kristensen, D. Wide-Swensson, C. Schmidt, S. Blirup-Jensen, V. Lindstrom, and H. Strevens Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia Acta Obstet Gynecol Scand 86 8 2007 921 926 (Pubitemid 47123595)
57. H. Strevens, D. Wide-Swensson, and A. Grubb Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate Scand J Clin Lab Invest 61 7 2001 575 580 (Pubitemid 33702365)
58. K. Kristensen, V. Lindstrom, C. Schmidt, S. Blirup-Jensen, A. Grubb, and D. Wide-Swensson Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process Scand J Clin Lab Invest 67 6 2007 612 618 (Pubitemid 351411738)
59. B. Thilaganathan, E. Ralph, A.T. Papageorghiou, K. Melchiorre, and J. Sheldon Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia Reprod Sci 16 8 2009 Aug 788 793
60. B. Thilaganathan, B. Wormald, C. Zanardini, J. Sheldon, E. Ralph, and A.T. Papageorghiou Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia Obstet Gynecol 115 6 2010 Jun 1233 1238
61. A. Farina, C. Zucchini, A. Sekizawa, Y. Purwosunu, P. de Sanctis, and G. Santarsiero Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks Am J Obstet Gynecol 203 6 2010 Dec 575e1 575e7
62. J.F. Mouillet, T. Chu, and Y. Sadovsky Expression patterns of placental microRNAs Birth Defects Res A Clin Mol Teratol 91 8 2011 Aug 737 743
63. E.J. Wortelboer, M.P. Koster, H.S. Cuckle, P.H. Stoutenbeek, P.C. Schielen, and G.H. Visser First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia BJOG 117 11 2010 Oct 1384 1389
64. F. Audibert, I. Boucoiran, N. An, N. Aleksandrov, E. Delvin, and E. Bujold Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women Am J Obstet Gynecol 203(4) 383 2010 Oct e1 e8
65. A.O. Odibo, Y. Zhong, K.R. Goetzinger, L. Odibo, J.L. Bick, and C.R. Bower First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia Placenta 32 8 2011 Aug 598 602
66. N. Hadker, S. Garg, C. Costanzo, J.D. Miller, T. Foster, and W. van der Helm Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective J Med Econ 13 4 2010 728 737
67. H.S. Cuckle Screening for pre-eclampsia-lessons from aneuploidy screening Placenta 32 Suppl 2011 Feb S42 S48